Articles published by VectivBio AG
VectivBio to Report Full Year 2022 Financial Results and Provide Business Update on Wednesday, April 19, 2023
April 12, 2023
From VectivBio AG
Via GlobeNewswire
Tickers
VECT
VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan
March 13, 2023
From VectivBio AG
Via GlobeNewswire
Tickers
VECT
VectivBio Announces Results of Extraordinary General Meeting
December 09, 2022
From VectivBio AG
Via GlobeNewswire
VectivBio Publishes Invitation to the Extraordinary General Meeting of Shareholders
November 16, 2022
From VectivBio AG
Via GlobeNewswire
Tickers
VECT
VectivBio to Present at the 2022 Jefferies London Healthcare Conference
November 09, 2022
From VectivBio AG
Via GlobeNewswire
Tickers
VECT
VectivBio Announces Closing of $125 Million Underwritten Offering of Ordinary Shares
October 18, 2022
From VectivBio AG
Via GlobeNewswire
Tickers
VECT
VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares
October 13, 2022
From VectivBio AG
Via GlobeNewswire
Tickers
VECT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.